• Healthy participants as established by medical history and clinical examination before entering into the study.

• A male or female between, and including, 4 years and 6 years of age (i.e., from 4 year birthday until the day before the 7-year birthday) at the time of study intervention administration.

• Participant who previously received a first dose of varicella-containing vaccine in the second year of life.

• Participant who previously received a single dose of measles-, mumps-, rubella-containing vaccine in the second year of life.

• Written informed consent obtained from the participants' parent(s)/legally acceptable representative(s) (LAR[s]) prior to performance of any study-specific procedure (participant informed assent will be obtained from participants in line with local rules and regulations).

• Participants' parent(s)/LAR(s), who, in the opinion of the investigator, can and will comply with the requirements of the protocol (e.g., completion of electronic diaries [eDiaries], return for follow-up visits).